1. Home
  2. PBMWW vs IRWD Comparison

PBMWW vs IRWD Comparison

Compare PBMWW & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBMWW
  • IRWD
  • Stock Information
  • Founded
  • PBMWW N/A
  • IRWD 1998
  • Country
  • PBMWW Canada
  • IRWD United States
  • Employees
  • PBMWW 10
  • IRWD N/A
  • Industry
  • PBMWW
  • IRWD Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBMWW
  • IRWD Health Care
  • Exchange
  • PBMWW Nasdaq
  • IRWD Nasdaq
  • Market Cap
  • PBMWW N/A
  • IRWD N/A
  • IPO Year
  • PBMWW N/A
  • IRWD 2010
  • Fundamental
  • Price
  • PBMWW $0.01
  • IRWD $3.68
  • Analyst Decision
  • PBMWW
  • IRWD Buy
  • Analyst Count
  • PBMWW 0
  • IRWD 4
  • Target Price
  • PBMWW N/A
  • IRWD $12.00
  • AVG Volume (30 Days)
  • PBMWW N/A
  • IRWD 1.9M
  • Earning Date
  • PBMWW N/A
  • IRWD 02-13-2025
  • Dividend Yield
  • PBMWW N/A
  • IRWD N/A
  • EPS Growth
  • PBMWW N/A
  • IRWD N/A
  • EPS
  • PBMWW N/A
  • IRWD N/A
  • Revenue
  • PBMWW N/A
  • IRWD $378,418,000.00
  • Revenue This Year
  • PBMWW N/A
  • IRWD N/A
  • Revenue Next Year
  • PBMWW N/A
  • IRWD N/A
  • P/E Ratio
  • PBMWW N/A
  • IRWD N/A
  • Revenue Growth
  • PBMWW N/A
  • IRWD N/A
  • 52 Week Low
  • PBMWW N/A
  • IRWD $3.06
  • 52 Week High
  • PBMWW N/A
  • IRWD $15.70
  • Technical
  • Relative Strength Index (RSI)
  • PBMWW N/A
  • IRWD 48.59
  • Support Level
  • PBMWW N/A
  • IRWD $3.39
  • Resistance Level
  • PBMWW N/A
  • IRWD $4.05
  • Average True Range (ATR)
  • PBMWW 0.00
  • IRWD 0.29
  • MACD
  • PBMWW 0.00
  • IRWD 0.03
  • Stochastic Oscillator
  • PBMWW 0.00
  • IRWD 62.51

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: